Jennifer Skeen, Sue Beruti

Jan 09, 2015

BioTheranostics announced Jennifer Skeen has joined the firm as VP of clinical operations, while Sue Beruti joined the company as medical director.

Skeen has 10 years of clinical laboratory operations management experience and was previously at Pathway Genomics, Asuragen, and Alvern Clinical Laboratories. Beruti was most recently director of pathology and medical affairs at Genoptix, where she headed the Biopharma Medical Division and medical affairs group.